Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment.
about
Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic reviewHistory of primary immunodeficiency diseases in iranPrimary immunodeficiencies and susceptibility to parasitic infections.Clinical predictors of primary immunodeficiency diseases in children.Prevalence and morbidity of primary immunodeficiency diseases, United States 2001-2007.X-linked agammaglobulinemia in a 10-year-old child: a case study.Does the route of immunoglobin replacement therapy impact quality of life and satisfaction in patients with primary immunodeficiency? Insights from the French cohort "Visages".The demographics of primary immunodeficiency diseases across the unique ethnic groups in Iran, and approaches to diagnosis and treatment.A cohort of French pediatric patients with primary immunodeficiencies: are patient preferences regarding replacement immunotherapy fulfilled in real-life conditions?Primary immunodeficiency diseases in Egyptian children: a single-center study.Primary immunodeficiency disorders: survey of pediatricians in Kuwait.Primary immunodeficiency diseases: practice among primary care providers and awareness among the general public, United States, 2008.Quality of Life, Treatment Beliefs, and Treatment Satisfaction in Children Treated for Primary Immunodeficiency with SCIg.Distribution of primary immunodeficiency diseases in the Turk ethnic group, living in the northwestern Iran.Quality of life and health-care resource utilization among children with primary immunodeficiency receiving home treatment with subcutaneous human immunoglobulin.Safety and efficacy of subcutaneous human immunoglobulin in children with primary immunodeficiency.
P2860
Q28755847-39FB94EE-3DAB-4932-B8F7-F5B41BEA792EQ36244405-208C4C34-169B-4BC9-9685-F1E80F4EA081Q36624178-68A7AA3E-E55B-4A2F-A477-6A428B6A4976Q36628771-8B83EC0D-4A8C-421B-BF68-9DAA5DDE6C7FQ36763235-9DFDD934-A7EE-42D3-8D7D-C14DA9CE07BEQ36790062-DA6C80D8-5FAB-4351-9E76-F6EBD8528226Q37031111-E1B8A7A2-AA66-4E5A-A73E-F9FCB885081BQ37962986-827C8494-12D5-4858-BF0A-EDE227313914Q38661420-3C2E0B23-4383-44DF-AB03-CDBDBED5D2CBQ39388582-141CE879-8A84-4B6B-9CC4-A318484AE7A8Q43943506-6059B3B1-02F6-4758-8AB5-F8DC2EE365B7Q45223763-17F4FCEB-66FA-43D0-83BA-D94C2D6B1502Q48302996-F622D966-5EC3-4C20-A863-3B925050328FQ51749224-28401564-F4E3-44C5-974D-E67C58467DE5Q51894105-D593549A-1BBE-4C6D-8E47-2FA577D72385Q53176831-C88E0CD1-35B5-43E5-BB7C-E8A9F4AA6A15
P2860
Primary immunodeficiency disorders in children: prompt diagnosis can lead to lifesaving treatment.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@ast
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@en
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@nl
type
label
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@ast
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@en
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@nl
prefLabel
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@ast
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@en
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@nl
P1476
Primary immunodeficiency disor ...... lead to lifesaving treatment.
@en
P2093
Catherine Champi
P356
10.1016/S0891-5245(02)25178-0
P577
2002-01-01T00:00:00Z